SCHEMBL30962655

SCHEMBL30962655

COc1nc(Nc2ccc(OC3CCN(C(=O)OC(C)(C)C)CC3)c(C)c2)ncc1C(=O)Nc1c(Cl)cccc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.42
▸ SRC P12931 2/20 0.41
▸ CCNK O75909 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ CCND3 P30281 1/20 0.41
▸ CDK9 P50750 1/20 0.41
▸ CDK6 Q00534 1/20 0.41
▸ ERBB2 P04626 4/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GPR35 Q9HC97 1/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ NR3C1 P04150 2/20 0.39
▸ ALK Q9UM73 2/20 0.38
▸ TOP2A P11388 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962749 0.96 PIK3CD (0.43) EGFRSRCCCNKCCNA2CDK2
SCHEMBL30962666 0.94 JAK3 (0.42) EGFRSRCCCNKCCNA2CDK2
SCHEMBL30962835 0.90 JAK3 (0.41) EGFRSRCCCNKCCNA2CDK2
SCHEMBL30962930 0.90 SRC (0.46) EGFRSRCERBB2
SCHEMBL30962929 0.90 SRC (0.46) EGFRSRCERBB2
SCHEMBL30962748 0.88 SRC (0.44) EGFRSRCERBB2
SCHEMBL30962895 0.88 SRC (0.44) EGFRSRCERBB2
SCHEMBL30962735 0.88 IGF1R (0.44) SRCCCNKCCNA2CDK2CCND3
SCHEMBL30962660 0.88 IGF1R (0.44) SRCCCNKCCNA2CDK2CCND3
SCHEMBL30962866 0.88 IGF1R (0.44) SRCCCNKCCNA2CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback